Given the involvement of S100A8 and S100A9 in leukemic progression and treatment resistance (48–50), these molecular changes highlight the possible therapeutic potential of acute exercise in modulating pro-inflammatory mediators in children with ALL in remission. This evidence concerns the gene S100A8 and acute lymphoblastic leukemia.